JEREMY SOMMER: Open Payments
NPI 1568891372 · AVENEL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,768 in 228 payments from 21 companies in 2025. Trend: 2023 $2,369 · 2024 $3,200 · 2025 $3,768
Food & beverage: $3,627Education: $140
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 25 | $504 |
| UCB, Inc. | 27 | $458 |
| Janssen Biotech, Inc. | 14 | $341 |
| Galderma Laboratories, L.P. | 23 | $292 |
| Lilly USA, LLC | 9 | $278 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $231 |
| Almirall LLC | 14 | $227 |
| Incyte Corporation | 14 | $196 |
| Novartis Pharmaceuticals Corporation | 12 | $190 |
| ABBVIE INC. | 18 | $180 |
Products named: Bimzelx, ADBRY, TREMFYA, EBGLYSS, OPZELURA, COSENTYX, SKYRIZI, Klisyri.
Industry payments across NJ — which companies pay providers there.
